PATENT CLAIM ANALYSIS

Application Number: 16004918
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "562000"]

Abstract:
This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for improving liver function and for treating liver diseases comprising administering an effective amount of the compositions to a subject in need thereof are also disclosed.

Claim (Index 16):
The composition of  claim 14 , wherein:\n e) the ratio of the R-amino acid entity to the S-amino acid entity is greater than 1:4, greater than 1:3, about 1:2, or about 9:20, and not more than 1.5:2 or 1:1; f) the ratio of the L-amino acid entity to the S-amino acid entity is greater than 1:3, greater than 1.5:3, about 2:3, or about 3:5, and not more than 2.5:3 or 1:15; g) the ratio of the L-glutamine to the S-amino acid entity is greater than 1:3, greater than 1.25:3, about 2:3, or about 3:5, and not more than 2.5:3 or 1:15; h) the ratio of the NAC entity to the S-amino acid entity or a salt thereof is greater than 1:8, greater than 1:7, or about 1:6, and not more than 1:5 or not more than 1.5:5; or i) a combination of two, three, or four of (e)-(h).

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.20588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15858444', '13701146', '14563362', '14394463', '15229942']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7071776118393778
- 35 USC 102 Novelty (BERT): 0.5928989470698924
- Combined Prediction Score: 0.6957497453624292
- Mean Citation Score: 327.007784
- Max Citation Score: 599.9713
- Similarity Product: 377.4052687851966

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test